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Abstract: In this study, we characterized the role of host cell protein tyrosyl-DNA phosphodiesterase
2 (TDP2) activity, also known as VPg unlinkase, in picornavirus infections in a human cell model of
infection. TDP2/VPg unlinkase is used by picornaviruses to remove the small polypeptide, VPg (Virus
Protein genome-linked, the primer for viral RNA synthesis), from virus genomic RNA. We utilized a
CRISPR/Cas-9-generated TDP2 knock out (KO) human retinal pigment epithelial-1 (hRPE-1) cell line,
in addition to the wild type (WT) counterpart for our studies. We determined that in the absence of
TDP2, virus growth kinetics for two enteroviruses (poliovirus and coxsackievirus B3) were delayed
by about 2 h. Virus titers were reduced by ~2 log10 units for poliovirus and 0.5 log10 units for
coxsackievirus at 4 hours post-infection (hpi), and by ~1 log10 unit at 6 hpi for poliovirus. However,
virus titers were nearly indistinguishable from those of control cells by the end of the infectious cycle.
We determined that this was not the result of an alternative source of VPg unlinkase activity being
activated in the absence of TPD2 at late times of infection. Viral protein production in TDP2 KO
cells was also substantially reduced at 4 hpi for poliovirus infection, consistent with the observed
growth kinetics delay, but reached normal levels by 6 hpi. Interestingly, this result differs somewhat
from what has been reported previously for the TDP2 KO mouse cell model, suggesting that either
cell type or species-specific differences might be playing a role in the observed phenotype. We also
determined that catalytically inactive TDP2 does not rescue the growth defect, confirming that TDP2
5′ phosphodiesterase activity is required for efficient virus replication. Importantly, we show for
the first time that polysomes can assemble efficiently on VPg-linked RNA after the initial round
of translation in a cell culture model, but both positive and negative strand RNA production is
impaired in the absence of TDP2 at mid-times of infection, indicating that the presence of VPg on
the viral RNA affects a step in the replication cycle downstream of translation (e.g., RNA synthesis).
In agreement with this conclusion, we found that double-stranded RNA production (a marker of viral
RNA synthesis) is delayed in TDP2 KO RPE-1 cells. Moreover, we show that premature encapsidation
of nascent, VPg-linked RNA is not responsible for the observed virus growth defect. Our studies
provide the first lines of evidence to suggest that either negative- or positive-strand RNA synthesis
(or both) is a likely candidate for the step that requires the removal of VPg from the RNA for an
enterovirus infection to proceed efficiently.
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1. Introduction
The Picornaviridae comprise a diverse family of viruses that includes both circulating and
re-emerging human pathogens. While the most well-studied among them is poliovirus, for which there
is an effective vaccine, other members such as human rhinovirus (HRV), enterovirus (EV) D68, EV-71,
coxsackieviruses (CV), and hepatitis A still represent major health concerns worldwide, particularly
for those who are immunocompromised or who have pre-existing conditions [1]. Of particular
concern is the resurgence of EV-D68, which was the cause of the 2014 outbreak in North America and
Europe of severe lower respiratory illness [2], mainly in children. The virus has also been implicated
as the infectious agent responsible for the recent incidence of non-polio acute flaccid paralysis [3].
Furthermore, several other picornaviruses also have a distinct neurotropism (e.g., EV71 and CVA
group viruses), making them major causes of aseptic meningitis and encephalitis globally [4].
As their name suggests, picornaviruses are small, positive-sense RNA viruses. There are 29
genera currently described in the family and the genome size ranges from ~7 to 9 kb. The genomic
RNA is uncapped at the 5′ end, and viral translation is mediated by an internal ribosome entry site
(IRES) within the 5′ noncoding region (NCR). Compared to the de novo initiation of RNA synthesis
employed by most RNA viruses, picornaviruses utilize a unique mechanism to replicate their genome.
RNA replication involves the use of the protein primer, VPg (Virus Protein genome-linked). Two uridine
monophosphate residues are added to VPg at Tyr3 by the viral RNA-dependent RNA polymerase
(RdRp), 3Dpol, to form the substrate VPg-pUpU [5]. This uridylylation reaction is templated by an
RNA structure called the cre, or cis-acting replication element, located at different positions within the
picornavirus coding sequence depending on the virus species [5–8] or in the case of foot-and-mouth
disease virus, within the 5′ NCR [5]. VPg-pUpU is then elongated by 3Dpol and as a result, all nascent
picornavirus RNAs, both positive- and negative-sense, are linked to VPg via a 5′ phosphotyrosyl
bond. Interestingly, however, VPg uridylylation at the cre has been shown to be dispensable for
negative-strand RNA synthesis [9] and that the 3′ poly(A) tract is likely the template for this reaction
when uridine triphosphate levels are not limiting [10].
For several decades, it has been known that the different forms of viral RNA which arise during the
picornavirus replication cycle have differential linkages to VPg [11–15]. Specifically, VPg was shown to
be removed from positive-sense RNA destined for translation and subsequent negative-strand RNA
synthesis by a cellular enzymatic activity termed “VPg unlinkase” based on its function [16]. More
than thirty years later, the identity of unlinkase was determined to be the cellular DNA repair enzyme,
tyrosyl-DNA phosphodiesterase 2 (TDP2) [17]. Picornaviruses hijack the 5′ phosphodiesterase function
of TDP2, which in the uninfected cell, is normally involved in the resolution of stalled topoisomerase 2
cleavage complexes on cellular DNA [18].
Several questions emerged following the discovery of TDP2 as VPg unlinkase. Chief among them
is whether removal of VPg from the RNA by TDP2 is necessary for efficient virus replication. Previous
studies addressed this question using a mouse embryonic fibroblast (MEF) cell model of picornavirus
infection and found that in the absence of TDP2, poliovirus, HRV1A, and CVB3 virus production
is either significantly reduced or completely abolished [19]. In addition, protein accumulation for
both poliovirus and CVB3 is severely diminished in TDP2 KO MEFs [19]. These findings suggested
that picornaviruses require the presence of TDP2 to efficiently carry out their replication cycles in a
mouse cell model of virus infection. However, it is unclear which step(s) in the cycle requires the
removal of VPg by TDP2. Unlinking of VPg has been shown not to be necessary for the initial round of
translation and replication of the incoming RNA template [20], indicating that the requirement for
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TDP2 activity occurs at a later step during infection. It has been suggested that removal of VPg might
prevent the premature encapsidation of nascent positive-sense RNA [17] based on the pattern of TDP2
redistribution observed during infection and the fact that only newly-synthesized VPg-linked RNA has
been shown to be packaged [21]; however, this has not yet been demonstrated directly. Other studies
have shown that VPg-linked RNA can efficiently form a translation complex in vitro [22] but whether
this is true in vivo after the initiating round of translation is unknown.
To replicate their genomic RNA, picornaviruses must generate a negative-strand template from
which copies of positive-strand RNA are produced. Negative-strand RNA synthesis in picornaviruses
involves the assembly of two key viral and host cell proteins into a ribonucleoprotein complex (RNP)
at a 5′ terminal RNA structure called the cloverleaf or stem-loop I [23]. These proteins include the
host factor, PCBP2, and the viral protein 3CD proteinase (3CDpro) [24,25]. PCPB2 binds to stem-loop
(SL) “b” located within the first 30 nucleotides of the 5′ end and to a C-rich region 10 nucleotides
downstream of SL “d” of the cloverleaf, adjacent to the IRES [24,26], while 3CDpro binds within SL
“d” [23]. The PCBP2/3CDpro 5′ RNP complex is thought to act as a scaffold to recruit factors required for
RNA synthesis and to facilitate circularization of the RNA, allowing synthesis of the antisense template
to initiate at the 3′ poly(A) tract [27,28]. The structure of the cloverleaf and binding of the complex is
illustrated in Figure 1. Interestingly, the PCBP2/3CDpro complex has also been shown to be required
for positive-strand RNA synthesis [29]. The proposed model predicts that the binding of the complex
at the 5′ end of nascent positive sense strands acts to reinitiate the synthesis of subsequent copies
of positive-sense RNA on the same negative-strand template [29]. Additionally, the PCBP2/3CDpro
RNP complex also has been shown to stabilize the viral RNA [30–32], given that picornavirus RNA is
uncapped and, as such, is subject to degradation by host exonucleases [33].
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Figure 1. Binding of PCBP2 and 3CDpro to the poliovirus 5′ cloverleaf structure. Host RNA binding
protein PCBP2 (green orbs) and viral 3CD proteinase (3CDpro, purple orb) form a ternary complex
with the 5′ cloverleaf structure of the viral RNA to initiate positive- and negative-sense RNA synthesis.
Formation of this complex is postulated to facilitate circularization of the RNA template which is
thought to be important for the synthesis process. Image of the structure was generated with CLC Main
Workbench Version 7.7.3. using the DNA sequence of the cloverleaf within the plasmid, pT7-PV1 [34].
Plasmid is used to in vitro transcribe viral RNA.
It was demonstrated that while the addition of a 5′ 7-methylguanosine cap also stabilizes poliovirus
RNAs containing mutations which disrupt the cloverleaf structure, doing so abolishes negative-strand
RNA synthesis in vitro [28]. This result was also observed when the cap was added to wild type RNA,
albeit, the effect was modest [28]. Furthermore, it is known that a precise 5′ end of the poliovirus
RNA is required for efficient positive-strand RNA synthesis [35], and the addition of one or two
extra nucleotides which are not encoded by the genome results in diminished positive strand RNA
production in vitro and delayed overall RNA replication in transfected cells [35]. In contrast, Langereis
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et al. showed that small chemical modifications to the 5′ end (i.e., the addition of a biotin molecule,
a Cy5 adduct, or an amine group) did not affect the initiating round of translation or replication of
the RNA [20]. Altogether, these data suggest that there may be certain classes of alterations to the
5′ end of picornavirus positive-sense RNA which might disrupt viral RNA synthesis, possibly as a
result of destabilization of the 5′ cloverleaf structure and/or a decrease in the binding efficiency of the
5′ PCPB2/3CDpro RNP complex. These data suggest that although removal of VPg is not necessary
to initiate the virus infection, there is(are) a step(s) beyond initiation of the picornavirus replication
cycle that requires TDP2. However, the exact step(s) and the overall picture of how the presence of
VPg on the viral RNA might interfere remains to be determined. Therefore, we carried out a series of
experiments using a human retinal pigment epithelial cell line ablated of TDP2 to test the hypothesis
that either viral mRNA translation and/or RNA synthesis requires the removal of VPg from the RNA
to allow a poliovirus or coxsackievirus infection to proceed efficiently. Our findings suggest that
efficient viral RNA synthesis is dependent on the removal of VPg from template RNAs by the activity
of TDP2/VPg unlinkase.
2. Materials and Methods
2.1. Cell Culture and Virus Stocks
Wild type (WT) and knock-out (KO) TDP2 hTERT RPE-1 (hRPE-1) cell lines were created
as previously reported [36]. In brief, we used a 17-bp gRNA sequence targeting TDP2 exon 4
(5′-GTAGAAATATCACATCT-3′) and cloned into the guide RNA vector #41824 (AddGene). The TDP2
guide construct was co-transfected with hCas9 expressed from plasmid #41815 (AddGene). Transfected
cells were enriched by G418 (Thermo Fisher, Waltham, MA, United States) selection for 5 days before
isolation of single clones and screening for loss of TDP2 expression by Western blotting. WT, KO,
and FLAG-tagged TDP2-expressing hRPE-1 cells were grown as monolayers in Ham’s F-12 media
containing 10% fetal bovine serum. The latter two cell lines were also grown in the presence of 800
µg/mL G418. HeLa cells used for plaque assays were grown as monolayers in Dulbecco’s modified
Eagle’s medium (DMEM) containing 8% newborn calf serum (NCS). HeLa cells used for the purpose
of generating virus stocks were grown in suspension culture in suspension minimal essential medium
containing 8% NCS and subsequently in methionine-free DMEM.
Poliovirus-1 (Mahoney strain), coxsackievirus B3-0, and EMCV were used to infect WT and
KO TDP2 hRPE cells or tagged TDP2-expressing cells. Radiolabeled poliovirus virion RNA was
generated using the W1-VPg31 virus [37]. EMCV/polio bicistronic virus was generated from the
construct pT7RibPVE2A(MluI) [38]. Luciferase-expressing poliovirus was generated from the construct
pT7R-Luc-PPP [39]. All virus stocks except PV-PPP were expanded by three serial passages in
HeLa cells.
2.2. Generation of 35S-Methionine-Labeled VPg-Linked RNA Substrate and VPg Unlinkase Assay
W1-VPg31 virus was used to generate the 35S-methionine (35S-met)-labeled VPg-linked RNA
substrate as described by Rozovics et al. [40]. Briefly, ~8 × 109 HeLa cells were grown in suspension
culture and subsequently infected with W1-VPg31 at a multiplicity of infection (MOI) of 20. The infected
cells were methionine-starved for 2 h, after which 2.5 mCi of 35S-met was added to the infected cell
suspension in a dropwise fashion. The cells were then incubated for 3.5 additional hours. Virion RNA
(vRNA) was then purified from the infected, radiolabeled cells as previously described [40].
The rapid in vitro VPg unlinkase assay was carried out as described [40]. In brief, 1 µL of
radiolabeled vRNA substrate (equivalent to 1000–5000 CPM) was incubated with recombinant
TDP2, whole cell lysates, or RNAse A in unlinkase buffer (20 mM Tris-HCl, pH 7.5, 1 mM DTT,
5% (v/v) glycerol) and in the presence of 2 mM MgCl2 for a total of 30 min at 30 ◦C. Reactions
mixtures were pre-incubated without the vRNA for 10 min after which time the RNA was added.
Reactions were then incubated further for 20 min at the indicated temperature. The reactions were
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subsequently loaded onto an SDS-containing, 13.5% polyacrylamide gel in Tris-tricine and resolved
by electrophoresis for 3.5 h. The gel was dried for 1 h and visualized by autoradiography using a
phosphor screen. TDP2 recombinant proteins used included GST-tagged TDP2 that was expressed from
the pGEX-2TK2-GST-EAPII plasmid kindly provided by Runzhao Li, formerly of Emory University;
6x histidine-tagged WT or catalytically inactive TDP2 that was expressed from the pET-15b vector.
Lysates included those generated from the following cell lines: WT or KO TDP2 hRPE-1; FLAG-tagged
WT or catalytically inactive TDP2-expressing hRPE-1.
2.3. Generation of Tagged TDP2-Expressing hRPE Cell Lines
Flag-tagged TDP2-expressing hRPE-1 cells were generated using the hTERT RPE-1 cell line ablated
of TDP2 by CRISPR/Cas9 targeting exon 4 (KO hRPE-1). WT TDP2 or TDP2 containing an alanine point
mutation at position 351 in the polypeptide (H351A) was excised from the pET-15b plasmid with XbaI
and EcoRI and purified by gel extraction. The purified product was amplified by PCR using forward
5′ GGAAGTCTAGAATTTGGGGAGTTGCC and reverse 5′ GGAAGGAATTCTTATTATATCTAAGT 3′
primers, subsequently digested with EcoRI and KpnI, and ligated into the N-terminal pCMV-FLAG
vector (Sigma, St. Louis, MO, United States) which was also digested with EcoRI and KpnI and
treated with alkaline phosphatase. The resulting plasmid DNAs were sequenced and purified
using cesium chloride gradients. KO TDP2 hRPE-1 cells were seeded onto 10 cm2 plates and were
subsequently transfected with the pCMV-FLAG-TDP2, FLAG-H351A, or empty FLAG vector as a
negative control using jetPRIME transfection reagent (Polyplus transfection, New York, NY, United
States). G418-resistant colonies were isolated and expanded. Clones were maintained in Ham’s F12
medium containing 10% FBS and 2 mg/mL G418. FLAG-TDP2 expression was verified by Western
blot analysis.
2.4. Virus Infections and Single Cycle Growth Analysis
hRPE-1 cells were grown in monolayers in 6-well plates at a density of 4.0 × 105 cells/well.
Media was removed and cells were washed twice with 1× PBS and subsequently infected with either
poliovirus or CVB3 at a MOI of 3 or, where indicated, 0.1. Virus adsorption was carried out at room
temperature for 30 min for poliovirus and 45 min for CVB3. The cells were then washed once with
1X PBS, serum-containing media was added back to the cells, which were incubated at 37 ◦C for the
indicated time periods. Cells and supernatant were harvested and subjected to four freeze-thaw cycles.
Infectious particle production was quantified by plaque assay. Virus yields are represented as plaque
forming units per cell and plotted on a logarithmic scale. Experiments were done in biological triplicate.
Error is reported as standard deviation of the mean.
2.5. Preparation of Lysates from Uninfected and Infected Cells and Western Blot Analysis
Cells were collected and centrifuged at 1500 RPM in 1.5 mL Eppendorf tubes. The cell pellet was
washed once with 1X PBS and resuspended in 1% NP-40 lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM
NaCl, 1% (v/v) NP-40). Cell suspensions were incubated on ice for 15 min. Debris was pelleted and
protein concentration of the lysate was determined by Bradford assay. For Western blot analysis of eIF4G
cleavage and poliovirus 3AB expression in WT and KO TDP2 cells, 50 µg of protein was loaded onto an
SDS-containing 12.5% polyacrylamide gel, subjected to electrophoresis, and transferred onto a PVDF
membrane. Membrane was blocked in 5% milk for 1 h and incubated with the primary and secondary
antibodies for 1 h and 45 min, respectively. The membrane was washed four times in 0.01% PBS-tween
in between primary and secondary antibody incubations. Anti-poliovirus 3A antibody (which also
recognizes 3AB) was used at a dilution of 1:2000. The mouse monoclonal against 3A was kindly
provided by George Belov, University of Maryland. Rabbit monoclonal antibody against eIF4G was
purchased from Cell Signaling Technologies and was used at a dilution of 1:2000. Anti-pan enterovirus
VP1 antibody (Agilent, Santa Clara, CA, United States) was used at a dilution of 1:1000; Anti-PKM2
(Bethyl, Montgomery, TX, United States) was used at a concentration of 1:5000 to detect endogenous
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PKM2 as a protein loading control. Anti-FLAG (Agilent) and anti-GFP (Abcam, Cambridge, United
Kingdom) were used at a dilution of 1:1000 to detect FLAG- and GFP-tagged proteins, respectively.
Protein bands were visualized by ECL Western Blotting Substrate (Life Technologies, Carlsbad, CA,
United States).
2.6. Generation of Renilla Luciferase Reporter Virus and Luciferase Assays
For the generation of Renilla luciferase-expressing polio reporter virus, Rluc-PV-PPP, RNA was
in vitro-transcribed and subsequently transfected into HeLa cells. The construct pT7-Luc-PPP was
linearized using PvuI prior to in vitro transcription. pT7-Luc-PPP was generously provided by Eckard
Wimmer, Stony Brook University. Reactions were carried out using a MEGAscript T7 transcription kit
(Thermo Fisher, Waltham, MA, United States). Transfected cells were collected 24 h post-transfection
and subjected to four freeze-thaw cycles to release infectious virus. Cell debris was pelleted and
supernatants were used to infect WT and KO TDP2 hRPE-1 cells.
2.7. Polysome Profile Analysis and Quantitation of Viral RNA Production
Polysome analysis was carried out as described [41]. WT and KO TDP2 hRPE cells were seeded
onto five 10 cm2 plates at a density of 7 × 105 cell/plate. Cells were infected with poliovirus as described
above and incubated for the indicated times at 37 ◦C. The infected cells were then incubated with
cycloheximide diluted in 50% ethanol at a concentration of 30 mg/mL for 3 min. Media was removed
and cells were subsequently washed once with 1× PBS containing 30 mg/mL cycloheximide. Cells were
scraped into 10 mL of 1X PBS containing cycloheximide and centrifuged at 1500 RPM for 5 min. PBS
was removed and cells were resuspended in 1.6 mL of polysome lysis buffer (300 mM NaCl, 15 mM
MgCl2, 10 mM Tris-HCl, pH 7.5, 1% (v/v) Triton-X) with 10 µg/mL cycloheximide for 30 min on ice.
Cell suspension was centrifuged at 14,000× g, debris was removed, and the lysates were frozen at
−80 ◦C. The samples were subsequently thawed on ice, 800 µL of which was applied to a continuous
10–50% sucrose gradient and centrifuged at 30,000 RPM in a SW41 swinging bucket rotor for 2 h at
4 ◦C. The remaining 800 µL of lysate was used to represent the total viral RNA content. Samples were
removed and subjected to polysome profile analysis in which twenty 500 µL fractions were generated.
The first 10 fractions were recovered for analysis. The fractions were subsequently frozen at −80 ◦C
until further analysis.
Samples were thawed on ice and RNA content from each fraction was purified by
phenol-chloroform extraction. Samples from fractions 1-2, 3-4, 5-6, 7-8, and 9-10 were pooled.
In parallel, RNA was extracted from the equivalent volume of unfractionated sample using the TRIzol
reagent (Invitrogen, Carlsbad, CA, United States). RNA concentration was measured in the pooled
fractions and the unfractionated sample, and cDNA was prepared from 1 µg of total cellular RNA.
One-step, real-time quantitative PCR (qRT-PCR) using SYBR green (Thermo-Fisher) was then carried
out to quantitate poliovirus RNA levels. qRT-PCR analysis was done in technical duplicate. GAPDH
mRNA levels were used as an internal control. RNA levels for the polysome analysis experiments
were recorded as the relative expression value of poliovirus RNA obtained from either the fractionated
or unfractionated sample and are normalized to that of GAPDH. RNA production is plotted as the
ratio of the normalized values obtained from the fractionated sample to those of the unfractionated
sample. Time course analysis of RNA production followed the same steps as the preparation of
polysome-associated RNA except that the levels of RNA are represented only as the normalized relative
expression values.
2.8. Encapsidation Inhibition Assays
WT TDP2 hRPE cells were seeded into 6-well plates at a density of 2.5 × 105. Virus infections were
carried out as previously described in “Virus Infections and Single Cycle Growth Analysis” section in
the presence of 6.25, 12.5, 25, 50, or 100 µg/mL of Hydantoin or DMSO alone as a negative control.
Viruses 2020, 12, 166 7 of 24
Cells were subsequently harvested 6 h post-infection and analyzed for infectious particle production
by plaque assay or for RNA production by qRT-PCR.
2.9. Immunofluorescence Assays
WT and KO TDP2 cells (2.5 × 105 cells/well) were seeded onto coverslips placed into 6-well plates.
Cells were infected with poliovirus as indicated and fixed in 3.7% formaldehyde at room temperature
at the indicated times for 10 min. Formaldehyde was removed and fixed cells were washed twice in
1× PBS and subsequently stored at 4 ◦C. The cells were subsequently permeabilized with 0.5% NP-40
in PBS for 5 min and were then washed 3 times with 1% NCS in 1× PBS. Cells were blocked in 1%
donkey serum in 200 µL of 1% bovine serum albumin (BSA) for 30 min at room temperature. The cells
were washed again 3 times with 1% NCS and incubated with the primary mouse monoclonal antibody
against double-stranded RNA (J2, Scions) for 2 h at a dilution of 1:200 in 1% BSA. After incubation,
the coverslips were washed 3 times with 1% NCS and then incubated with the fluorescent secondary
anti-mouse antibody (Dylight 488, Bethyl) for 30 min. Coverslips were then washed 3 times with 1%
NCS and counterstained with DAPI to label nuclei. Coverslips were mounted onto microscope slides
using Fluoro-gel (Electron Microscopy Sciences, Hatfield, PA, United States) and imaged using a Zeiss
LSM700 confocal fluorescence microscope at 63×magnification.
3. Results
3.1. TDP2 Protein Expression and VPg Unlinkase Activity Are Absent in TDP2 Knock-Out hRPE-1 Cells
To determine the effect of maintaining VPg on viral RNA during the picornavirus replication cycle,
we utilized a human retinal pigment epithelial (hRPE-1) cell model of infection. While previous studies
used mouse embryonic fibroblast cells (MEFs) to address whether TDP2 is required for virus replication
(40), there are certain aspects of this model that do not faithfully recapitulate human infections with
picornaviruses. Specifically, it was observed that host cap-dependent translation is not shut off
during CVB3 infection of MEFs (Ullmer and Semler, unpublished observations); however, this is a
canonical feature of picornavirus infection of human cells [42]. To circumvent potential species-specific
differences that might confound interpretation of the results, we chose to use hRPE-1 cells. hRPE-1 cells
are differentiated from neuroectoderm and are therefore of the neuronal cell lineage [43], making them
a suitable human cell model given that our viruses of interest are neurotropic. Furthermore, it has been
shown that in the presence of certain transcription factors, hRPE-1 can differentiate into neuron-like
cells [44,45].
We carried out an initial characterization of the TDP2 WT and KO RPE-1 cell lines to confirm that
both VPg unlinkase activity and TDP2 protein expression are absent in the KO cells (Figure 2). To test
the former, we used a rapid, in vitro VPg unlinkase assay developed by Rozovics et al. [40] that relies
on a 35S-methionine (35S-met)-labelled virion RNA substrate. Poliovirus engineered to contain two
extra methionine residues in the VPg polypeptide sequence [37] was grown in the presence of 35S-met,
allowing the VPg to be radiolabeled. The labelled RNA was isolated and subsequently incubated with a
source of TDP2/VPg unlinkase (either recombinant protein or whole cell lysates). The entire reaction mix
was then subjected to electrophoresis on an SDS-containing, 13.5% polyacrylamide gel in Tris-tricine
buffer and analyzed by autoradiography. Released VPg can be observed as a radioactive signal
migrating towards the bottom of the gel. As expected, we observed that cell lysates generated from WT
TDP2 hRPE-1 cells possess VPg unlinkase activity (Figure 2A, lane 3), while those generated from KO
TDP2 cells do not (Figure 2A, lane 4). As a positive control, we used recombinant WT TDP2 (Figure 2A,
lane 2). For a negative control, we used a catalytically inactive version of the enzyme containing an
alanine substitution at His351 (Figure 2A, lane 5), which has been shown previously to abolish TDP2 5′
phosphodiesterase activity [46]. To control for non-specific, non-phosphodiesterase-mediated release
of VPg, we treated the radiolabeled substrate with RNAse A (Figure 2A, lane 1), which generates
VPg-pU and therefore migrates with a higher molecular mass than VPg alone. We also determined by
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Western blot analysis that TDP2 protein expression is absent in hRPE-1 TDP2 KO cells compared to
WT (Figure 2B). Altogether, these data confirm that hRPE1 TDP2 KO cells are devoid of detectable
TDP2/VPg unlinkase activity and protein expression.
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Figure 2. TDP2 protein expression and VPg unlinkase activity are absent in KO RPE cells. (A) Lysates
from wild type (WT) and knock out (KO) TDP2 hRPE cells (WT and KO RPE) were generated and
used as sources of VPg unlinkase to determine unlinkase activity on a radiolabeled VPg-linked RNA
substrate. Release of VPg from the RNA is indicated by the free VPg signal at the bottom of the gel.
Recombinant WT (WT TDP2) and catalytically inactive TDP2 (H351A) were used as positive and
negative controls, respectively. RNAse A was used as a control for non-phosphodiesterase-mediated
unlinking of VPg. vRNA alone was also used as a negative control. (B) Western blot analysis was carried
out on WT and KO TDP2 hRPE cell lysates. Pyruvate kinase M2 (PKM2) was used as a loading control.
3.2. Virus Growth Kinetics Are Delayed in the Absence of TDP2 for Poliovirus and CVB3 in hRPE-1 Cells,
and the Effect is MOI-Dependent
We infected the WT and KO TDP2 hRPE-1 cells with either poliovirus or CVB3 at a multiplicity of
infection (MOI) of 3 and carried out single cycle growth analyses to determine virus growth kinetics.
As depicted in Figure 3A,B, we observed an approximate 2 log10 and 0.5 log10 unit reduction in virus
titer at 4 hpi for poliovirus and CVB3, respectiv ly, and ~1 log10 reduction at 6 hpi for poliovirus.
The growth defect was enhanced for CVB3 when the cells were infected at a l wer MOI of 0.1 (Figu e 3C).
From these data, we concluded that virus growth is delayed in the absence of TDP2 and that this effect
s both virus and MOI-dependent.
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Figure 3. Virus growth kinetics are delayed in the absence of TDP2 for poliovirus and CVB3 in hRPE-1
cells, and the effect is multiplicity of infection (MOI)-dependent. (A–C) Single cycle growth analyses
were carried out on either poliovirus- or CVB3-infected WT and KO TDP2 hRPE cells (2.5 × 105) over
an 8 h infection time course. Cells were infected either at a MOI of 3 (poliovirus and CVB3) or 0.1
(CVB3). Infected cells and supernatants were harvested at the indicated time points, subjected to
4 freeze-thaw cycles, and the virus titer was determined by plaque assay. Infectious particle production
is represented as plaque forming units (PFU) per cell. Error bars indicate the standard deviation of the
results. Experiments were performed in biological triplicate.
3.3. Poliovirus Titers Are Comparable in WT and KO RPE cells after Multiple Replication Cycles
We observed that both poliovirus and CVB3 virus titers reach normal levels in TDP2 KO cells at
the end of the infectious cycle (8 hpi) and are indistinguishable from those obtained from WT cells.
Moreover, it appeared that for poliovirus, the rate of virus production was increased in the TDP2 KO
cells between 4 to 6 hpi, based on the slope of the line and the titer at 6 hpi, compared to that of the
equivalent time points in WT cells. We considered whether an early delay in growth kinetics in the
absence of TDP2 might lead to higher overall virus production after multiple replication cycles. This
would suggest that the presence of VPg on the RNA might slow down virus replication in a way that is
advantageous to the virus specifically in contexts where TDP2 is limiting. However, we found this not
to be the case, and virus titers from WT and KO TDP2 cells are comparable after 1 or 2 replication
cycles (Figure 4).
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Figure 4. Poliovirus titers are comparable in WT and KO RPE cells after multiple replication cycles.
WT and KO TDP2 hRPE cells were infected with poliovirus at a MOI of 3. Cells and supernatant were
harvested at 0, 16, or 24 hpi and plaque assays were car ied out to determine the vir s titer. I fectious
particl producti n as well as st tistic l error a rep esented as indicated in Fig re 3. Data are the
verage of three biological replicates.
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3.4. eIF4G is Cleaved in both WT and KO TDP2 RPE Cells during Poliovirus Infection
As mentioned above, it has been demonstrated that host cap-dependent translation is not shut
off during CVB3 infection of MEF cells. This is noteworthy because ongoing host translation during
the virus infection increases the competition between virus and host mRNAs for ribosomes and other
translation initiation factors [47], which has the potential to make the overall virus replication cycle
inefficient. As such, it could be difficult to parse out the effect of TDP2 KO on virus replication vs. the
inherent inefficiency of picornavirus translation in mouse cells. This was a key factor in our decision
to develop the hRPE-1 cell model of infection. Therefore, we examined whether host translation is
shut off during picornavirus infection of hRPE-1 cells to determine if the growth defect we observed
was due to an indirect effect of host competition for translation resources. We either infected or
mock-infected the WT and KO TDP2 cell lines with poliovirus and generated extracts at 0, 4, or 8 hpi.
Using Western blot analysis, we assayed for the cleavage of the eukaryotic initiation factor, eIF4G.
Poliovirus 2Apro-mediated proteolysis of eIF4G is required for host translation shut-off [48] and is
routinely used as a read-out for this step. As displayed in Figure 5, eIF4G cleavage products could be
detected as early as 30 min post-infection (after the virus adsorption period, indicated as 0 hpi time
points in Figure 5) and were the most prominent at 8 hpi for both the WT and KO TDP2 cell lines.
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Figure 5. eIF4G is cleaved in both WT and KO TDP2 RPE cells during poliovirus infection. WT and KO
TDP2 hRPE cells were infected at an MOI of 3 and incubated at 37 ◦C for the indicated time periods.
Cells were harvested, washed once with 1× PBS, and centrifugated at 15,000 RPM in a benchtop
Eppendorf centrifuge. Cell pellet was resuspended in 1% Nonidet P 40 Substitute (NP-40) lysis buffer
and incubated on ice for 15 min. Debris was removed and protein concentration was determined. Fifty
µg of protein from each sample was loaded onto a 12.5% polyacrylamide, SDS-containing gel and
subjected to electrophoresis for 2 h at 200 V. Proteins ere transferred overnight to a polyvinylidene
difluoride (PVDF) membrane and Western blot analysis was carried out. PKM2 expression was used as
a loading control. Poliovirus structural protein VP1 expression was used as a control for virus infection.
eIF4G cleavage pro ucts are indicated.
3.5. An Alternative Source of VPg Unlinkase Activity Is Not Activated at Late Times of Infection in TDP2 KO
hRPE-1 Cells
In our single cycle growth studies, we noted that, while virus production was hampered at
mid-times of infection, this delay was overcome later during the infection cycle (6-8 hpi). It was
possible that the activation of an alternative source of VPg unlinkase activity in the absence of TDP2
could account for this increase in virus titer. In fact, several other cellular enzymes in addition to
TDP2 have recently been reported to participate in the resolution of stalled TOP2 cleavage complexes,
including FEN1 (flap endonuclease 1) [49] and MRE11 (meiotic recombination 11), a double-stranded
break repair protein [50]. To determine if an alternative source of VPg unlinkase activity was activated
at late times of infection, we generated lysates from either WT or KO TDP2 mock- or poliovirus-infected
hRPE-1 cells that were collected at 6 hpi and used them to carry out a VPg unlinkase assay. We
determined that, in contrast to the WT TDP2 cells, the virus-infected KO cells did not possess any
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discernible VPg unlinkase activity (Figure 6, compare lanes 2 and 4), demonstrating that the activation
of a redundant 5′ phosphodiesterase is not responsible for the recovered virus growth observed late
during poliovirus infection.
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Figure 6. An alternative source of VPg unlinkase activity is not activated at late times of infection in
TDP2 KO hRPE-1 cells. WT and KO TDP2 hRPE cells were infected or mock-infected with poliovirus at
an MOI of 3 and harvested at 6 hpi. Cell lysates were prepared and VPg unlinkase assay was carried
out as indicated in the legend to Figure 2. Recombinant WT TDP2 was used as a positive control.
3.6. TDP2 5′ Phosphodiesterase Activity Is Required for Efficient Poliovirus Replication
In addition to DNA repair, TDP2 has other roles in the uninfected cell [51]. Several of the pathways
in which TDP2 is involved have been shown to also play roles in picornavirus replication. For example,
overexpression of TDP2 has been demonstrated to activate the MAPK-ERK signal cascade resulting
in an increase in cell proliferation [52]. Additionally, it is known that efficient CVB3 replication is
dependent on the activation of the MAPK-ERK pathway [53,54] and is also influenced by the cell
cycle [55]. Furthermore, TDP2 blocks the activation of the NF-κB pathway via its interactions with the
CD40 receptor and TRAF6 [56], and several picornaviruses including poliovirus, HRV14, echovirus
1 [57] and EV71 [58] have also been shown to downregulate NF-κB signaling by targeting either
the p65-RelA subunit of the NF-κB complex for 3Cpro-mediated degradation, or by blocking IKKβ
activation through interactions with 2C to promote virus replication [58]. Thus, it is possible that
a function of TDP2 which is independent of its 5′ phosphodiesterase activity might be involved in
picornavirus replication and could therefore be responsible for the growth defect we observed in
TDP2 KO hRPE cells. To test this possibility, we generated hRPE cell lines that constitutively express
FLAG-tagged versions of either WT TDP2 (FLAG-TDP2) or the catalytically inactive protein containing
the H351A mutation (FLAG-H351A) described previously (refer to Figure 2). These cell lines were
created using the CRISPR TDP2 KO cells as the backbone. We determined the relative protein expression
level of FLAG-TDP2 and FLAG-H351A in the complemented cells by Western blot analysis (Figure 7A)
and chose clones which had comparable recombinant TDP2 protein expression levels for the remainder
of our studies. We assessed the levels of VPg unlinkase activity in both cell lines. As expected, lysates
of FLAG-TDP2-expressing cells (Figure 7B, lane 4) were able to hydrolyze VPg from the RNA similarly
to lysates from WT cells (Figure 7B, lane 3), while those from FLAG-H351A-expressing cells were not
(Figure 7B, lane 7), and VPg unlinkase activity was comparable to that of KO TDP2 cells. (Figure 7B,
lane 6). As positive and negative controls for this experiment, we used recombinant GST-tagged TDP2
and vRNA alone (Figure 7B, lanes 2 and 8, respectively). We next infected both cell lines (FLAG-TDP2
and FLAG-H351A) with poliovirus and included either WT or KO TDP2 cells as positive and negative
controls, respectively. Single cycle growth analysis allowed us to determine if catalytically inactive
TDP2 is able to rescue the delay in virus production observed in TDP2 KO cells, suggesting that other
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functions of TDP2 (aside from its DNA repair activity) may be playing a role in the virus replication
cycle. However, we observed that the catalytically inactive version of TDP2 is unable to rescue virus
replication (Figure 7C, dashed red line) and that growth kinetics are comparable to those in the negative
control. In contrast, consistent with previously published results [19] FLAG-TDP2 can rescue the
virus growth defect (Figure 7C, dashed blue line), and titers are similar to those from WT TDP2 cells.
Our data demonstrate that TDP2 5′ phosphodiesterase activity is important for efficient poliovirus
replication and most likely acts directly on VPg-linked RNA. However, it is important to note that
this experiment does not rule out the possibility that there are other cellular pathways which are
activated by TDP2 enzymatic activity that picornaviruses also require to carry out their replication
cycles. Such putative pathways have yet to be described, and the signal cascades mentioned above
rely only on TDP2 activation via protein-protein interactions and not its enzymatic activity. Given the
unique DNA/RNA-protein linkages upon which TDP2 acts, it is unlikely that this activity is used to
activate a signaling pathway directly.
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Our initial characterizations of picornavirus infection in the absence of TDP2 revealed that 
infectious virus particle production was delayed. However, there are several steps at which TDP2 
VPg unlinkase could act during the replication cycle that would result in a decrease in total virus 
yield. To further dissect the mechanism underlying this observation, we first assessed virus protein 
production in the absence of TDP2 in hRPE-1 cells. If protein production is impaired, this would 
suggest a defect in either virus translation and/or RNA synthesis mediated by the presence of VPg 
on the viral RNA, given that protein accumulation during infection is the aggregate of both activities. 
We tested virus protein production in the absence of TDP2 both qualitatively by Western blot analysis 
and quantitatively using a Renilla luciferase-expressing poliovirus reporter [39], termed PV-PPP, 
which is depicted in Figure 8B. We infected the WT and KO TDP2 hRPE-1 cells with either WT 
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(A) estern blot analysis was carried out on FLAG-tagged WT or H351A catalytically inactive
TDP2-expressing hRPE-1 cells as described in Figure 5. (B) VPg unlinkase assay was carried out as
described in the legend to Figure 2 using the following sources of enzyme activity: Lane 1, RNAse
A; Lane 2, recombinant GST-tagged TDP2; Lane 3, WT TDP2 hRPE-1 cell lysate; Lane 4, FLAG-TDP2
hRPE-1 cell lysate; Lane 5, recombinant His-tagged TDP2; Lane 6, KO TDP2 hRPE-1 cell lysate;
Lane 7, FLAG-H351A hRPE-1 cell lysate; Lane 8, vRNA alone (negative control). Lysates were
prepared as described in the legend to Figure 5. Bands at the top the gel are non-specific degradation
products. (C) Single-cyc e growth analysis of poliovirus infection in WT TDP2, KO TDP2, FLAG-TDP2,
or FLAG-H351A-expressing hRPE-1 cells lines.
3.7. Poliovirus Protein Production Is Delayed in the Absence of TDP2 in hRPE-1 Cells
Our initial characterizations of picorn virus inf ction in th absence of TDP2 revealed that
infectious virus particle production was delayed. However, there are sev ral st ps at which TDP2
VPg unlinkase could act during the replication cycle that would result in a decrease in total virus
yield. To further dissect the mechanism underlying this observation, we first assessed virus protein
production in the absence of TDP2 in hRPE-1 cells. If protein production is impaired, this would
suggest a defect in either virus translation and/or RNA synthesis mediated by the presence of VPg on
the viral RNA, given that protein accumulation during infection is the aggregate of both activities.
We tested virus protein production in the absence of TDP2 both qualitatively by Western blot analysis
and quantitatively using a Renilla luciferase-expressing poliovirus reporter [39], termed PV-PPP, which
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is depicted in Figure 8B. We infected the WT and KO TDP2 hRPE-1 cells with either WT poliovirus or
the luciferase reporter virus and harvested infected cells at 2 h intervals throughout the 8 h time course
of infection. We then carried out Western blot analysis on the infected cell lysates, probing for the viral
protein 3AB, or luciferase assays to quantify virus protein accumulation. Consistent with our previous
observations of infectious particle output, there was a substantial delay in the virus protein production
in the TDP2 KO cells that could be observed in both assays at 4 hpi but was recovered between 6 and
8 hpi (Figure 8, panels A and C).
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Figure 8. Poliovirus protein production is delayed in the absence of TDP2 in hRPE-1 cells. (A) Western
blot analysis of poliovirus-infected WT and KO hRPE-1 cells. Cells were infected with poliovirus
and harvested at the indicated times. Lysates were prepared as described in the legend to Figure 5.
Poliovirus 3AB protei expression wa detected using a mouse monoclonal antibody against 3A
(generously provided by George Belov, University of Maryland), which also recognizes the precursor
protein, 3AB. PKM2 expression was used as a loading control. (B) Schemati of th Renilla l ciferase
reporter virus construct, PV-PPP [39]. (C) Quantitation of luciferase production by PV-PPP in WT
and KO TDP2 hRPE-1. Cells were infected with 200 µL of inoculum containing PV-PPP (MOI 0.01)
and incubated at 37 ◦C for the indicated time periods. Cells were lysed using Passive Lysis Buffer
(Promega) and luciferase activity was determined using a luminometer. Values are presented as Relative
Luminometer Units (RLU) per second. PV-PPP construct was generously provided by Eckard Wimmer,
Stony Brook University. Error bars represent the standard deviation of the results obtained from three
biological replicates.
3.8. Polysomes Can Assemble Efficiently on VPg-Linked RNA after the Initial Round of Translation and
Replication in Cultured Cells
To tease apart the contribution of a potential defect in either virus translation or RNA synthesis to
the growth phenotype observed, we examined virus translation directly by polysome profile analysis.
It has been suggested that removal of VPg from viral RNA during picor avirus infectio s all ws for
efficient polysome association during nfectio [13,16], although it has been d monstrated in vitro
that VPg-linked RNA can form translation-compete t RNP complexes [22]. To test if the presence of
VPg hampers polyribosome loading onto viral RNA during picornavirus infection of cultured cells,
we infected WT and KO TDP2 RPE cells with poliovirus and treated the cells with cycloheximide to
stall the actively translating ribosomes on the RNA. We collected the samples at 2 or 4 hpi, generated
lysates from the infected cells, and fractionated them through a 10–50% sucrose gradient, after which
we carried out polysome profile analysis on the fractionated lysates. We then purified the total RNA in
each fraction by phenol-chloroform extraction and quantified the viral RNA content by qRT-PCR. Viral
RNA content i the fr ctions was n rmalized t GAPDH expression and is repr sented as a ratio of the
total, unfracti nated cytoplasmic viral RNA content in an equivalent s mple volume generated from
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either WT or KO cells. If VPg acts as an impediment to polysome formation, we would expect that a
majority of the viral RNA obtained from the KO TDP2 cells would appear in the slower-sedimenting
monosome fractions, indicative of free ribosomes, or in the 40 or 60S fractions, suggesting a block in
ribosome assembly. However, as shown in Figure 9A–C, the majority of poliovirus RNA detected in
both WT and KO TDP2 cells falls into either the 80S monosome (5–6) or the low molecular weight
(i.e., slower sedimenting) polysome (7–10) fractions at 2 hpi. This suggests that polyribosomes can load
efficiently onto VPg-linked RNA after the initial rounds of translation and RNA replication. Moreover,
the ratio of polysome-associated viral RNA to total WT or KO cytoplasmic viral RNA content is
comparable, demonstrating that early virus translation is not impaired in the absence of TDP2.
When we quantified the viral RNA content of the fractions at 4 hpi, we found that although the
polysome profile was comparable in WT and KO TDP2 RPE cells, in which most of the viral RNA was
observed to be in the low molecular weight polysome fractions (7-8) (Figure 9, panels D and E), the total
levels of viral RNA obtained from the KO cells were substantially lower than those from WT cells.
This is depicted as the ratio between KO polysome-associated viral RNA and WT total cytoplasmic
viral RNA (Figure 9F). These results indicate that although viral translation can proceed normally
on VPg-linked RNA, the RNA fails to amplify at mid-times of infection (i.e., 4 hpi) in the absence of
TDP2. We confirmed this finding by treating infected cells with guanidine hydrochloride (GuHCl),
a potent inhibitor of poliovirus RNA synthesis. As shown in Figure 10, panels A–C, viral RNA is able
to associate with polysomes in the absence of active RNA synthesis. Importantly, in Figure 10, panel D,
the ratio of total viral RNA obtained from GuHCl-treated cells compared to untreated WT cells is
comparable to that observed in untreated KO cells.
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out to quantitate viral RNA present in each fraction. Values obtained for each set of pooled fractions 
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viral RNA present in the total unfractionated, cytoplasmic sample generated from WT (A,C,D, and F) 
or KO (B and E) TDP2 hRPE-1 cells. 
Figure 9. Polysomes can assemble efficiently on VPg-linked RNA after the initial round of translation
in cultur d cells, but vir l RNA fails to amplify at mid-times of infection. Polysome analysis f WT or
KO TDP2 hRPE-1 cells infected with poliovirus at an MOI f 3 collected at 2 hpi (A–C) r 4 hpi (D–F).
Infected cells were treated with 30 mg/mL of cycloheximide for 3 min then lysed in polysome lysis
buffer on ice for 30 min. Lysate was then layered onto a continuous 10–50% sucrose gradient. Gradients
were centrifugated at 30,000 RPM in an SW41 swinging bucket rotor for 2 h at 4 ◦C and subjected to
polysome fractionation at 4 ◦C. RNA was purified, and qRT-PCR analysis was carried out to quantitate
viral RNA present in each fraction. Values obtained for each set of pooled fractions are standardized to
GAPDH mRNA levels and are represented as the normalized value relative to viral RNA present in the
total unfractionated, cytoplasmic sample generated from WT (A,C,D,F) or KO (B,E) TDP2 hRPE-1 cells.
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and ~3 log10 unit reduction in positive and negative-strand RNA production at 4 hpi, respectively, in 
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RNA production does not reach WT levels at the end of the infectious cycle. This may indicate that 
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RNAs at this time during the infection are being immediately packaged into virus particles that exit 
from the host cell and therefore cannot be quantified in our analysis. 
 
Figure 10. Polysomes can assemble efficiently in the absence of genome amplification. (A) Treatment
of poliovirus-infected WT and KO hRPE cells with increasing concentrations of GuHCl. Cells were
harvested at 4 hpi. (B–D) Polysome analysis as carried out in Figure 9 except that cells were treated
with 2.5 mM GuHCl to inhibit viral RNA synthesis. In panel (D), polysome-associated viral RNA
collected from WT or KO hRPE cells treated with GuHCl is represented as a ratio of the total cytosolic
viral RNA collected from mock-treated, poliovirus-infected WT cells.
3.9. V Synth sis Is Delayed in he Absence of TDP2 in hRPE Cells
We followed up the results obtained from our polysome analysis to validate the observed decrease
in viral RNA levels at 4 hpi. in TDP2 KO cells. We carried out an 8 h infection time course for
poliovirus in WT and KO TDP2 RPE cells, collected cell lysates at 2 h intervals, TRIzol-extracted the
total cellular RNA, and quantified the viral RNA content by qRT-PCR. In this experiment, we quantified
both positive- and negative-strand RNA production. In agreement with what we observed in the
polysome experiments and consistent with our viral growth kinetics data, we saw a ~2 log10 and
~3 log10 unit reduction in positive and negative-strand RNA production at 4 hpi, respectively, in TDP2
KO cells compared to WT, and a ~1-2 log10 reduction at 6 hpi (Figure 11, A and B), suggesting that
viral RNA synthesis is impaired on VPg-linked RNA templates. Unlike infectious particle output,
RNA production does not reach WT levels at the end of the infectious cycle. This may indicate that
either fewer positive-sense RNA strands are synthesized in KO RPE cells or that positive-strand RNAs
at this time during the infection are being immediately packaged into virus particles that exit from the
host cell and therefore cannot be quantified in our analysis.
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Figure 11. Viral RNA synthesis is delayed in the absence of TDP2 in hRPE cells. Positive- (A) or
negative- (B) strand RNA production was quantitated for poliovirus over an 8-h infection time course
in WT and KO TDP2 hRPE-1 cells. Cells were infected with poliovirus at an MOI 3. RNA was extracted
from the infected cells at the indicated times post-infection using TRIzol reagent. qRT-PCR analysis
was carried out as described in the legend to Figure 10 and Materials and Methods. Relative expression
values for viral RNA production are standardized to those of GAPDH mRNA levels at each time point.
3.10. Premature Encapsidation of Viral RNA Is not Responsible for Observed Growth Phenotype in the Absence
of TDP2
Implicit in the idea that RNA synthesis is impaired in the absence of TDP2 is that there are
fewer positive- and/or negative-strand RNA templates available upon which RNA synthesis can occur,
thereby delaying the virus replication cycle. Another possibility to account for this phenomenon is
the premature encapsidation of nascent, positive-strand VPg-linked RNA. Virgen-Slane et al. initially
proposed that the presence or absence of VPg might act as a “mark” for the virus to distinguish RNA
destined for translation, RNA synthesis, or encapsidation [17]. Cleavage of the VPg-RNA linkage early
on during a wild-type virus infection would preclude the packaging of viral RNA too soon, which
would truncate the infection. This hypothesis is based on the fact that poliovirus has been demonstrated
to re-localize TDP2 from the nucleus to the cytoplasm at mid times of infection. Moreover, TDP2 forms
a distinctive pattern in HeLa cells late during the infection in which the protein is localized adjacent
to but does not co-localize with markers of virus replication complexes [17]. The interpretation of
this is that TDP2 may be excluded from sites of replication when VPg unlinkase activity is no longer
required at late times of infection. Furthermore, it is known that only nascent, VPg-linked RNA is
encapsidated [21] and that, although VPg does not function as a packaging signal per se, the protein
does interact with the viral precursor 3CD which is thought to promote packaging [59].
To test if the growth defect we observed in the absence of TDP2 was due to premature packaging
of the viral RNA, we used a known picornavirus encapsidation inhibitor called hydantoin [60], which
at low concentrations (<50 µg/mL) blocks virion maturation but leaves both virus translation and RNA
synthesis unaffected. At concentrations >50 µg/mL, however, RNA synthesis is also diminished [61].
We reasoned that if viral RNA is packaged too soon during the replication cycle in the absence of
TDP2 and if this is responsible for the growth kinetics delay, then blocking encapsidation should
rescue the delayed virus replication phenotype. First, we carried out a dose response of the drug
in poliovirus-infected RPE cells to determine the appropriate concentration to use such that only
viral RNA packaging was affected. We infected WT TDP2 hRPE cells in the presence of increasing
concentrations of hydantoin (0 µg/mL–100 µg/mL), harvested the cells at 6 hpi, and determined
the virus titer by plaque assay. In concurrent experiments, we extracted RNA from drug-treated,
poliovirus-infected WT hRPE cells and quantified the positive-sense viral RNA content by qRT-PCR.
Figure 12, panels A and B, demonstrate that while virus production is reduced starting at the 25 µg/mL
concentration, viral RNA production is not affected until the highest concentration of the drug is
reached (100 µg/mL), consistent with previously published data demonstrating a divergence in the
concentration of the drug required to achieve a block in packaging vs. in RNA synthesis. We used the
25 µg/mL concentration for the remainder of our experiments.
Viruses 2020, 12, 166 17 of 24
Since these experiments entail blocking encapsidation, infectious particle production cannot be
used as a read-out. Instead, we utilized the Renilla luciferase-expressing reporter virus described earlier
(Figure 8). We treated WT and KO TDP2 hRPE-1 cells with either DMSO or 25 µg/mL of hydantoin,
infected these cells with the reporter virus, harvested the cells at 6 hpi, and carried out luciferase
assays on the cell lysates. As observed previously, luciferase expression is reduced in TDP2 KO cells
compared to WT in the vehicle-treated condition (Figure 12C). Importantly, however, this reduction is
not rescued in the presence of hydantoin (Figure 12C), indicating that premature encapsidation of the
viral RNA is not responsible for the growth phenotype.
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Figure 12. Premature encapsidation is not responsible for observed growth phenotype in the absence
of TDP2. (A) Encapsidation inhibition assay. WT and KO TDP2 hRPE-1 cells were infected with
poliovirus in the presence of 6.25, 12.5, 25, 50, or 100 µg/mL of the encapsidation inhibitor, hydantoin,
or DMSO (mock) as a negative control. Cells were harvested at 6 hpi and virus particle production
was determined by plaque assay and represented as described in Figure 2. (B) qRT-PCR analysis of
hydantoin-treated, poliovirus infected WT and KO TDP2 hRPE-1 cells. (C) Infection of WT and KO
TDP2 hRPE-1 with PV-PPP treated with 25 µg/mL hydantoin or mock-treated with DMSO. Luciferase
assays were carried out as described in the legend to Figure 9.
3.11. Replicative Form (RF) and/or Replicative Intermediate (RI) Formation Is Delayed in TDP2 KO
hRPE-1 Cells
Picornavirus RNA replication results in the formation of a double-stranded RNA (dsRNA)
intermediate, termed the re li tive form (RF), w ich consists of nascent negative-s nse RNA uplexed
to a positiv -sense RNA tem late and occurs during negative- trand RNA synth sis. It also produces
a replicative intermediate (RI) form, which is c mp ised of multiple nasce t positive-strands being
synthesized from the same negative-sense template and forms during positive-stra d RNA synthesis.
RF and RI are detected by host innate immune sensors (e.g., RIG-I and MDA5), and the virus has
developed mechanisms to antagonize these pathways [62,63]. Important to the current study is that
an antibody has been eveloped (den ted “J2”) which also recognizes dsRNA above 40 base pairs in
length [64] and is frequently used to detect RNA virus replication. We used this antibody to determine
the relative dsRNA production in virus-inf cted WT and KO TDP2 cells. If the ab ndance of dsRNA
is creased in the absence of TDP2, this would indicate that either RF or RI formation is impaired,
further suggesting that either positive or negative-strand RNA synthesis (or both) is inefficient on
VPg-linked viral RNA templates. To test this, we seeded WT and KO TDP2 RPE cells onto coverslips,
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mock-infected or infected them with poliovirus, and fixed the cells at 2 or 4 hpi. We then carried out
immunofluorescence assays on the infected cells to visualize dsRNA using the J2 antibody. We found
that, consistent with the time course analysis of viral RNA production, the signal for double-stranded
RNA appears to be lower in virus-infected KO TDP2 cells at both 2 and 4 hpi (Figure 13), compared to
WT, indicating that the generation of the RF and/or RI is also delayed in the absence of TDP2.
Viruses 2020, 12, x FOR PEER REVIEW 18 of 24 
 
 
Figure 13. RF and/or RI formation is delayed in TDP2 KO hRPE-1 cells. Immunofluorescence assays 
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anti-mouse DyLight 488 (Bethyl) fluorescent antibody was used to detect J2. Cells were 
counterstained with DAPI to detect nuclei. Coverslips were mounted onto microscope slides and 
imaged at 63x magnification as described in the Materials and Methods. 
4. Discussion  
In this study, we demonstrated that the DNA repair enzyme, TDP2, is required for efficient 
picornavirus replication in human RPE cells and that this is dependent on its 5′ phosphodiesterase 
activity. Furthermore, we showed that removal of VPg is not necessary for polysome association with 
the viral RNA after the initiating round of translation, but that viral RNA production and viral 
double-stranded intermediate formation is impaired in the absence of TDP2.  
While our findings are overall in agreement with previously published work on the requirement 
for TDP2 activity during picornavirus infections [19], they diverge in the degree to which the enzyme 
is required for virus replication. Maciejewski et al. reported a striking reduction in virus titers for 
CVB3 infection in TDP2 KO mouse embryo fibroblast (MEF) cells, whereby virtually no new 
infectious particles were produced over the course of one infectious cycle (10 hpi) or after multiple 
replication cycles (24 hpi) [19]. Additionally, the authors reported that for poliovirus infection in the 
absence of TDP2, although virus titers do increase over the infection time course, they do not reach 
the level of those obtained from WT TDP2 MEF cells by the end of the infectious cycle [19]. In contrast, 
we observed only a modest decrease (~0.5 log10 units) in virus production for CVB3 at 4 hpi in TDP2 
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Figure 13. RF and/or RI formation is delayed in TDP2 KO hRPE-1 cells. Immunofluorescence assays of
poliovirus-infected WT and KO TDP2 hRPE-1 cells. Mock-infected or poliovirus-infected cells were
fixed and treated as described in Materials nd Methods. J2 antibody was used to detect d RNA. Goat
anti-mouse DyLight 488 (Bethyl) fluorescent antibody was used to detect J2. Cells were counterstained
with DAPI to d tect nuclei. Coverslips were mounte onto microscope slides and imaged at 63x
magnification as described in the Materials and Methods.
4. Discussion
In this study, we demonstrated that the DNA repair enzyme, TDP2, is required for efficient
picornavirus replication in human RPE cells and that this is dependent on its 5′ phosphodiesterase
activity. Furthermore, we showed that removal of VPg is not necessary for polysome association
with the viral RNA after the initiating round of translation, but that viral RNA production and viral
double-stranded intermediate formation is impaired in the absence of TDP2.
While our findings are overall in agreement with previously published work on the requirement
for TDP2 activity during picornavirus infections [19], they diverge in the degree to which the enzyme
is required for virus replication. Maciejewski et al. reported a striking reduction in virus titers for
CVB3 infection in TDP2 KO mouse embryo fibroblast (MEF) cells, whereby virtually no new infectious
particles were produced over the course of one infectious cycle (10 hpi) or after multiple replication
cycles (24 hpi) [19]. Additionally, the authors reported that for poliovirus infection in the absence
of TDP2, although virus titers do increase over the infection time course, they do not reach the level
of those obtained from WT TDP2 MEF cells by the end of the infectious cycle [19]. In contrast, we
observed only a modest decrease (~0.5 log10 units) in virus production for CVB3 at 4 hpi in TDP2
KO hRPE-1 cells. Only when we infected cells at a lower MOI of 0.1 did we see a more substantial
reduction (1-1.5 log10 units) in virus titers. Furthermore, while we observed a considerable growth
kinetics delay at 4 hpi for poliovirus (~2 log10 units), virus production was fully recovered by the end
of the infectious cycle. We suggest that this difference in phenotype may be due to the cell models used.
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While we demonstrated that the eukaryotic initiation factor eIF4G is cleaved in both WT and KO TDP2
hRPE-1 cells during poliovirus infection, indicating that host cap-dependent translation is shut-off by
the virus, host translation continues to occur throughout CVB3 infection of MEFs (Ullmer and Semler,
unpublished observation). Therefore, it is possible that the competition between host and viral mRNAs
for ribosomes/translation resources in MEFs might amplify the defect in virus replication precipitated
by the presence of VPg on viral RNA, thus leading to the more dramatic growth phenotype observed
in MEFs. This could explain why picornaviruses have evolved to remove VPg from their RNA in the
first place. While the virus might be able to recover from a relatively minor delay in virus production
during infection of cultured cells, this delay might become more deleterious to the progression of the
virus infection in an in vivo context. This is because: 1) the virus would have to contend with the
host immune system; and 2) the MOI of a natural infection is orders of magnitude lower than what is
routinely used in cell culture experiments. In support of this latter possibility, we have demonstrated
that the growth delay in the absence of TDP2 is augmented at a lower MOI. As picornaviruses infect
multiple cell types during in vivo infections, each of which might support different levels of virus
replication, it would make sense for the virus to employ a mechanism to ensure that a small defect in
its replication strategy could be overcome.
In this study, we demonstrated directly that the 5′ phosphodiesterase activity of TDP2 is required
for efficient poliovirus replication in human cells. Although somewhat expected, this finding is
significant given that TDP2 has other cellular roles (aside from its DNA repair function) which have
also been shown to be involved in the replication cycle for several picornaviruses [58]. We also
determined that a redundant 5′ phosphodiesterase is not activated at late times of picornavirus
infection to account for the increase in virus replication observed. This suggests that the step in the
replication cycle affected by the presence of VPg on the RNA is inefficient but not completely defective,
and by virtue of either a feature inherent to the mechanism itself or another parallel facet of the virus
infection, the defect can eventually self-correct.
Given that the magnitude of the growth delay phenotype observed in TDP2 KO hRPE cells is
dependent upon the amount of input virus in the inoculum and is recovered at mid to late times of
infection (during the phase in which RNA is amplified exponentially), RNA synthesis is a plausible
candidate as the step which requires the removal of VPg from the RNA. Consistent with this suggestion,
we found that polysome association with viral RNA is unaffected in the absence of TDP2 and that the
majority of viral RNA was recovered from the low molecular weight polysome fraction for both WT
and KO TDP2 cells at 2 and 4 hpi. A previous study showed that a functional translation initiation
complex can be formed on VPg-linked RNA in vitro [22], and our data from cell culture infections are
consistent with this observation. Although earlier studies found that polysome-associated viral RNA
isolated from HeLa cell lysates is not linked to VPg, our findings suggest that there is likely a pool of
VPg-linked RNA that is also translated, even in the presence of TDP2/VPg unlinkase. The proportion of
total polysome-associated viral RNA that this pool might occupy, however, remains to be determined.
In contrast to the lack of a direct effect on poliovirus translation, the overall levels of viral RNA
recovered from the polysome fractions were reduced in the absence of TDP2 at 4 hpi, compared to what
was recovered from WT cells. This suggests that although VPg-linked RNA can be translated efficiently,
it fails to amplify at mid-times of infection. This result was validated by a time course analysis of both
positive and negative-sense RNA production, as well as by immunofluorescence assays demonstrating
that dsRNA formation (representative of viral RI and RF from positive- and negative-strand RNA
synthesis, respectively) is reduced in TDP2 KO cells at 2 and 4 hpi. Additionally, we determined that
virus protein production is also diminished at 4 hpi. As mentioned above, viral protein accumulation
is an amalgamation of the output from both translation and RNA synthesis. Putting these results in
the context of our findings from the polysome analysis, the observed delay in protein production is
most likely explained by the failure of the RNA to amplify efficiently.
When TDP2 was first discovered as VPg unlinkase, it was proposed that removal of VPg early on
during the replication cycle might act to prevent nascent RNA from being packaged prematurely [17,19].
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This would result in an early boost in virus particle production in TDP2 KO cells compared to WT
followed by an immediate plateau (i.e., logarithmic growth). However, this growth pattern has
never been observed. It is possible that a delay in virus particle production caused by premature
encapsidation might also eventually be overcome in the absence of TDP2, leading to the phenotype
that we observe in hRPE-1 cells. Our data demonstrated that the delay in protein production that
occurs at mid-times of infection in the absence of TDP2 is not rescued by blocking RNA packaging
using the inhibitor hydantoin, suggesting that encapsidation of VPg-linked RNA is not responsible for
the phenotype. Instead, we propose that the presence of VPg at the 5′ end of the RNA might hinder
the formation of the PCBP2/3CD RNP complex at the cloverleaf structure, a step that is required for
both positive and negative-strand RNA synthesis. Our model for this scenario is depicted in Figure 14.
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similar to those linking VPg to the viral RNA in uninfected human cells and how the presence of
DNA linked to protein by 5′ phosphotyrosyl bonds in the cytoplasm might be a putative signal for
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the activation of innate immune pathways [65]. It is conceivable that picornaviruses have evolved
to ensure that this type of linkage is not recognized by the host via hydrolysis of VPg from the RNA
immediately upon infection and during the early stages of replication. However, given the existence of
the mRNA decay pathways triggered by host cell recognition of virus-specific RNA features [33], any
putative deleterious effects of maintaining VPg on the viral RNA would have to be balanced with the
risk of exposing the 5′ monophosphate, which may be subject to 5′ → 3′ exonuclease degradation,
especially during the early phases of poliovirus infection prior to the proteasome-mediated degradation
of exonucleases like XRN 1 [66]. Interestingly, a recent report by Pyle and colleagues showed that
duplex RNAs harboring a 5′ monophosphate linkage antagonize the activation of the innate immune
sensor RIG-I [67], thereby providing a putative link between the TDP2-mediated cleavage of VPg
from picornavirus genomic RNAs and the antagonism of host cell RNA sensing pathways. Overall,
picornaviruses must manage a delicate equilibrium between the many activities that they undertake to
wrest control of the host cell, which is no mean feat for these small (but mighty) RNA viruses.
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